ClinicalTrials.gg
CompletedNCT06721793NRGUpdated Jan 27, 2026

The Impact of a Caffeinated Sports Drink on Performance

An interventional study of carbohydrate electrolyte drink and no-sugar electrolyte drink in Dehydration and Dehydration Related to Exercise, sponsored by Arizona State University. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-27.

Sponsored by Arizona State University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Caffeine is known to enhance physical and mental performance, but few beverages combine caffeine with electrolytes and carbohydrates to enhance exercise performance. This study evaluates a caffeinated electrolyte-glucose drink's effect on endurance, strength, and cognition. Using a repeated-measures, cross-over design, 20 trained cyclists will complete one familiarization and four randomized 3-hour experimental trials (Liquid I.V.™ Energy Multiplier, Hydration Multiplier, Sugar-Free Hydration Multiplier, and water). Each trial includes 2 hours of cycling in a warm environment (32ºC), followed by strength and cognitive assessments. Cycling performance, capillary blood, urine, and expiratory gases will be collected.

Read the detailed description

Each subject will complete 5 trials (1 familiarization and 4 experimental) consisting of approximately 2 hours cycling in a warm environment (90ºF), followed by strength assessment and cognitive assessment via questionnaire. Each trial will be identical, with the only difference being the type of drink consumed during each trial. The first trial will be for familiarization without any blood sampling. The rest of the trials will be completed in a randomized order and the drink consumed

Cycling Endurance Exercise Performance

The exercise test will consist of a series of three consecutive cycling sets in a warm environment (90ºF), with each series consisting of:

  1. a 30-min submaximal ride (50% maximal power as determined from the initial)
  2. a 5-km time trial race-like performance effort. During each 30 min submaximal rides participants will drink a total 500 mL of fluid spread out during the 30 min. During the 5 km performance test the participants will drink 25 mL of fluid at the end of each kilometer.

At regular intervals throughout the exercise task, body weight, blood samples, respiratory gasses, and perceptual data will be collected. See study schematic provided below for specific measurement timepoints.

Upon completion of the cycling task subjects will moved to another room with cool temperature (70ºF), where strength and cognitive function will be assessed to determine the influence of each beverage on indices of exercise performance and fatigue.

02

Conditions studied

  • Dehydration
  • Dehydration Related to Exercise

Browse trials for

Keywords

  • caffeine
  • sports drinks
  • hydration
03

In context

Dehydration

201 studies on the registry are indexed under Dehydration; 28 are open to participants now.

This study's enrollment of 26 is below the median of 43 across 145 interventional studies indexed under Dehydration.

Browse Dehydration studies →

Lead sponsor

Arizona State University is the lead sponsor of 238 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-55
  • Healthy and injury-free (muscle, skeletal) for greater than 2 months
  • Active cyclists who train at least 3 times per week
  • (BMI) range of 18.5-30 kg/m2

Exclusion criteria

Exclusion Criteria:

    • History of caffeine sensitivity

      • Cancer Diagnosis during the last 5 years
      • Pregnancy
      • History of renal disease, hypertension
      • History of a heat stroke
      • Use of testosterone therapy
      • Adults who are unable to consent (impaired decision-making capacity)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
26 participants (actual)

Study arms

  • Placebo comparator
    Water

    Water masked with non-caloric and no-sodium

    Dietary Supplement: Water (Placebo)

  • Experimental
    Carbohydrate electrolyte solution

    2% carbohydrate solution with 1,020 mg/L of Sodium

    Dietary Supplement: carbohydrate electrolyte drink

  • Experimental
    no-sugar electrolyte solution

    1% carbohydrate solution with 1,060 mg/L of Sodium

    Dietary Supplement: no-sugar electrolyte drink

  • Experimental
    Caffeinated carbohydrate electrolyte solution

    1% carbohydrate solution with 1,000 mg/L of Sodium, and 200mg/L Caffeine

    Dietary Supplement: Caffeinated Carbohydrate and electrolyte drink

Interventions

  • Dietary supplementcarbohydrate electrolyte drink

    2% carbohydrate solution with 1,020 mg/L of Sodium

  • Dietary supplementno-sugar electrolyte drink

    1% carbohydrate solution with 1,060 mg/L of Sodium

  • Dietary supplementCaffeinated Carbohydrate and electrolyte drink

    2% carbohydrate solution with 1,000 mg/L of Sodium, and 200mg/L caffeine

  • Dietary supplementWater (Placebo)

    flavored water with non-caloric, non-sodium-containing sweetner

06

What researchers measure

Primary outcomes

  1. 5 kilometer cycling time trial

    Time in minutes of completion the 5 kilometer cycling time trial at the 3rd exercise bout.

    Time frame: During the 3rd time trial which is the last time trial.

  2. 5 kilometer Time trial performance

    Time to completion the 2nd cycling time trial

    Time frame: 2nd time trial

  3. Isokinetic stregth

    Peak torque at 60º/sec at dominant knee during extension

    Time frame: right after the cycling tests

  4. Congitive performance 1

    Attention Network Test score

    Time frame: after the completion of strength test

  5. Cognitive performance 2

    Working Memory Test score

    Time frame: after the end of the strength assessment

  6. Congitive test 3

    Stroop Task score

    Time frame: right after the strength test

Secondary outcomes

  1. Blood glucose

    Blood glucose levels during the 3rd cycling time trial.

    Time frame: at the end of the 3rd cycling time trial.

07

Study locations

1 site
  • Arizona State University - Hydration Science Lab
    Phoenix, Arizona 85004, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06721793
Responsible party
Stavros Kavouras (Professor, Arizona State University) — Principal investigator
First posted
Dec 6, 2024
Start date
Dec 12, 2025
Primary completion
Dec 16, 2025
Completion
Dec 16, 2025
Last update
Jan 27, 2026

Study contacts

Stavros Kavouras, PhD
principal investigator · Arizona State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion